Kuros Biosciences AG (LON:0RHR)
London flag London · Delayed Price · Currency is GBP · Price in CHF
25.89
+1.07 (4.31%)
At close: Apr 29, 2025

Kuros Biosciences AG Revenue

In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M CHF with 125.11% growth.

Revenue
75.56M CHF
Revenue Growth
+179.89%
P/S Ratio
13.92
Revenue / Employee
619.30K CHF
Employees
122
Market Cap
927.05M GBP

Revenue Chart

Created with Highcharts 11.4.8Kuros Biosciences AG Revenue - Annual4.04M4.04M13.82M13.82M17.99M17.99M33.56M33.56M75.56M75.56M20202021202220232024-20M40M60M80M
* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202475.56M41.99M125.11%
Dec 31, 202333.56M15.58M86.61%
Dec 31, 202217.99M4.17M30.19%
Dec 31, 202113.82M9.78M242.04%
Dec 31, 20204.04M1.48M57.71%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings